An A.I. classifier derived from 4D radiomics of dynamic contrast-enhanced breast MRI data: potential to avoid unnecessary breast biopsies
- PMID: 33744990
- PMCID: PMC8270804
- DOI: 10.1007/s00330-021-07787-z
An A.I. classifier derived from 4D radiomics of dynamic contrast-enhanced breast MRI data: potential to avoid unnecessary breast biopsies
Abstract
Objectives: Due to its high sensitivity, DCE MRI of the breast (bMRI) is increasingly used for both screening and assessment purposes. The high number of detected lesions poses a significant logistic challenge in clinical practice. The aim was to evaluate a temporally and spatially resolved (4D) radiomics approach to distinguish benign from malignant enhancing breast lesions and thereby avoid unnecessary biopsies.
Methods: This retrospective study included consecutive patients with MRI-suspicious findings (BI-RADS 4/5). Two blinded readers analyzed DCE images using a commercially available software, automatically extracting BI-RADS curve types and pharmacokinetic enhancement features. After principal component analysis (PCA), a neural network-derived A.I. classifier to discriminate benign from malignant lesions was constructed and tested using a random split simple approach. The rate of avoidable biopsies was evaluated at exploratory cutoffs (C1, 100%, and C2, ≥ 95% sensitivity).
Results: Four hundred seventy (295 malignant) lesions in 329 female patients (mean age 55.1 years, range 18-85 years) were examined. Eighty-six DCE features were extracted based on automated volumetric lesion analysis. Five independent component features were extracted using PCA. The A.I. classifier achieved a significant (p < .001) accuracy to distinguish benign from malignant lesion within the test sample (AUC: 83.5%; 95% CI: 76.8-89.0%). Applying identified cutoffs on testing data not included in training dataset showed the potential to lower the number of unnecessary biopsies of benign lesions by 14.5% (C1) and 36.2% (C2).
Conclusion: The investigated automated 4D radiomics approach resulted in an accurate A.I. classifier able to distinguish between benign and malignant lesions. Its application could have avoided unnecessary biopsies.
Key points: • Principal component analysis of the extracted volumetric and temporally resolved (4D) DCE markers favored pharmacokinetic modeling derived features. • An A.I. classifier based on 86 extracted DCE features achieved a good to excellent diagnostic performance as measured by the area under the ROC curve with 80.6% (training dataset) and 83.5% (testing dataset). • Testing the resulting A.I. classifier showed the potential to lower the number of unnecessary biopsies of benign breast lesions by up to 36.2%, p < .001 at the cost of up to 4.5% (n = 4) false negative low-risk cancers.
Keywords: Breast MRI; Breast biopsies; Breast cancer; Neural network; Principal component analysis.
© 2021. The Author(s).
Conflict of interest statement
The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
Figures




Similar articles
-
Intra- and peri-tumoral radiomics based on dynamic contrast-enhanced MRI for prediction of benign disease in BI-RADS 4 breast lesions: a multicentre study.Radiat Oncol. 2025 Feb 28;20(1):27. doi: 10.1186/s13014-025-02605-y. Radiat Oncol. 2025. PMID: 40022114 Free PMC article.
-
Combination of ultrafast dynamic contrast-enhanced MRI-based radiomics and artificial neural network in assessing BI-RADS 4 breast lesions: Potential to avoid unnecessary biopsies.Front Oncol. 2023 Feb 1;13:1074060. doi: 10.3389/fonc.2023.1074060. eCollection 2023. Front Oncol. 2023. PMID: 36816972 Free PMC article.
-
High-temporal resolution DCE-MRI improves assessment of intra- and peri-breast lesions categorized as BI-RADS 4.BMC Med Imaging. 2023 Apr 19;23(1):58. doi: 10.1186/s12880-023-01015-4. BMC Med Imaging. 2023. PMID: 37076817 Free PMC article. Clinical Trial.
-
Can structured integration of BI-RADS criteria by a clinical decision rule reduce the number of unnecessary biopsies in BI-RADS 4 lesions? A systematic review and meta-analysis.Eur Radiol. 2025 Mar;35(3):1504-1513. doi: 10.1007/s00330-024-11274-6. Epub 2024 Dec 18. Eur Radiol. 2025. PMID: 39694886 Free PMC article.
-
Can supplementary contrast-enhanced MRI of the breast avoid needle biopsies in suspicious microcalcifications seen on mammography? A systematic review and meta-analysis.Breast. 2021 Apr;56:53-60. doi: 10.1016/j.breast.2021.02.002. Epub 2021 Feb 15. Breast. 2021. PMID: 33618160 Free PMC article.
Cited by
-
Radiogenomics analysis reveals the associations of dynamic contrast-enhanced-MRI features with gene expression characteristics, PAM50 subtypes, and prognosis of breast cancer.Front Oncol. 2022 Jul 28;12:943326. doi: 10.3389/fonc.2022.943326. eCollection 2022. Front Oncol. 2022. PMID: 35965527 Free PMC article.
-
An updated overview of radiomics-based artificial intelligence (AI) methods in breast cancer screening and diagnosis.Radiol Phys Technol. 2024 Dec;17(4):795-818. doi: 10.1007/s12194-024-00842-6. Epub 2024 Sep 16. Radiol Phys Technol. 2024. PMID: 39285146 Review.
-
Four-Dimensional Machine Learning Radiomics for the Pretreatment Assessment of Breast Cancer Pathologic Complete Response to Neoadjuvant Chemotherapy in Dynamic Contrast-Enhanced MRI.J Magn Reson Imaging. 2023 Jan;57(1):97-110. doi: 10.1002/jmri.28273. Epub 2022 May 28. J Magn Reson Imaging. 2023. PMID: 35633290 Free PMC article.
-
Intra- and peri-tumoral radiomics based on dynamic contrast-enhanced MRI for prediction of benign disease in BI-RADS 4 breast lesions: a multicentre study.Radiat Oncol. 2025 Feb 28;20(1):27. doi: 10.1186/s13014-025-02605-y. Radiat Oncol. 2025. PMID: 40022114 Free PMC article.
-
Breast Tumor Identification in Ultrafast MRI Using Temporal and Spatial Information.Cancers (Basel). 2022 Apr 18;14(8):2042. doi: 10.3390/cancers14082042. Cancers (Basel). 2022. PMID: 35454949 Free PMC article.
References
-
- Verburg E, van Gils C, Bakker M, et al (2020) Computer-aided diagnosis in multiparametric magnetic resonance imaging screening of women with extremely dense breasts to reduce false-positive diagnoses. Invest Radiol https://pubmed.ncbi.nlm.nih.gov/32149858/. Accessed 2 Jun 2020 - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous